Despite increased sales of its OsteoGram osteoporosis technology, Los Angeles-based medical informatics firm CompuMed posted lower revenues in fiscal year 2006 (end-September 30).
Revenues totaled $2.1 million, compared with $2.3 million in fiscal 2005. CompuMed attributed to decrease to a one-time sale of ECG terminals to the New York State Department of Corrections in fiscal 2005.
The company's net loss was $424,000 in fiscal 2006, compared with a loss of $336,000 in the previous fiscal year. CompuMed blamed the net loss on new staff hiring, product development, and future growth initiatives.
By AuntMinnie.com staff writers
December 29, 2006
Related Reading
CompuMed nets China install for OsteoGram, November 27, 2006
CompuMed signs Phillips, November 20, 2006
CompuMed revenues slip amid higher losses, August 14, 2006
CompuMed re-signs correction contracts, June 13, 2006
CompuMed revenues edge up, but loss widens, May 15, 2006
Copyright © 2006 AuntMinnie.com














![Representative example of a 16-year-old male patient with underlying X-linked adrenoleukodystrophy. (A, B) Paired anteroposterior (AP) chest radiograph and dual-energy x-ray absorptiometry (DXA) report shows lumbar spine (L1 through L4) areal bone mineral density (BMD). The DXA report was reformatted for anonymization and improved readability. The patient had low BMD (Z score ≤ −2.0). (C) Model (chest radiography [CXR]–BMD) output shows the predicted raw BMD and Z score in comparison with the DXA reference standard, together with interpretability analyses using Shapley additive explanations (SHAP) and gradient-weighted class activation maps. The patient was classified as having low BMD, consistent with the reference standard. AM = age-matched, DEXA = dual-energy x-ray absorptiometry, RM2 = room 2, SNUH = Seoul National University Hospital, YA = young adult.](https://img.auntminnie.com/mindful/smg/workspaces/default/uploads/2026/04/ai-children-bone-density.0snnf2EJjr.jpg?auto=format%2Ccompress&fit=crop&h=112&q=70&w=112)



